Longboard Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Viking Global Investors LP(5.2%),Viking Global Opportunities Parent GP LLC(5.2%)等
Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | 4:持股變動聲明-董事 SEKHRI PAUL J
Longboard Pharmaceuticals | 4:持股變動聲明-董事 SCHNEIDER PHILLIP M
Longboard Pharmaceuticals | 4:持股變動聲明-董事 Lynch Casey
Longboard Pharmaceuticals | 4:持股變動聲明-董事 Le Goff Corinne
Longboard Pharmaceuticals | 4:持股變動聲明-董事 Aurentz Vincent
Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | 10-Q:季度報表
Longboard Pharmaceuticals | 8-K:Longboard Pharmicals公佈2024年第一季度財務業績並提供公司最新情況
Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | ARS:年度報告
Longboard Pharmaceuticals | DEFA14A:其他
Longboard Pharmaceuticals | DEF 14A:股東委託書決議
Longboard Pharmaceuticals | PRE 14A:並購重組委托聲明
Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | S-8:員工福利計劃證券登記
Longboard Pharmaceuticals | S-3ASR:“知名成熟發行人”證券註冊聲明
Longboard Pharmaceuticals | 10-K:年度報表
暫無數據